Evidence map›Paper›PMID 38891766›Full record

ArticleInternational journal of molecular sciences2024

Bowman-Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities.

Won-Seok Kim, Jason D Gillman, Sunhyung Kim, Junqi Liu, Madhusudhana R Janga, Robert M Stupar, Hari B Krishnan

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Climate change and the antinutrient-antioxidant puzzle in common bean seeds.Journal of the science of food and agriculture · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Advances in Soybean Genetic Improvement.Plants (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Won-Seok KimDivision of Plant Science and Technology, University of Missouri, Columbia, MO 65211, USA.
Jason D GillmanPlant Genetics Research Unit, US Department of Agriculture-Agricultural Research Service, Columbia, MO 65211, USA.ORCID 0000-0003-3246-7417
Sunhyung KimDivision of Plant Science and Technology, University of Missouri, Columbia, MO 65211, USA.
Junqi LiuDepartment of Agronomy and Plant Genetics, University of Minnesota, St. Paul, MN 55108, USA.
Madhusudhana R JangaInstitute of Genomics for Crop Abiotic Stress Tolerance, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0002-3743-6006
Robert M StuparDepartment of Agronomy and Plant Genetics, University of Minnesota, St. Paul, MN 55108, USA.ORCID 0000-0002-8836-2924
Hari B KrishnanPlant Genetics Research Unit, US Department of Agriculture-Agricultural Research Service, Columbia, MO 65211, USA.

Funding

Minnesota Soybean Research and Promotion Council project 3006-11028-00103891United Soybean Board and Agricultural Research Service, USDA 2020-152-0114, 2335-203-0101, and 8042-21220-234-00D
6 · The paper itself

Abstract

Despite the high quality of soybean protein, raw soybeans and soybean meal cannot be directly included in animal feed mixtures due to the presence of Kunitz (KTi) and Bowman-Birk protease inhibitors (BBis), which reduces animal productivity. Heat treatment can substantially inactivate trypsin and chymotrypsin inhibitors (BBis), but such treatment is energy-intensive, adds expense, and negatively impacts the quality of seed proteins. As an alternative approach, we have employed CRISPR/Cas9 gene editing to create mutations in

Indexed as

Gene EditingGlycine maxTrypsin Inhibitor, Bowman-Birk SoybeanChymotrypsinCRISPR-Cas SystemsMutationPlant ProteinsPlants, Genetically ModifiedSeedsTrypsinTrypsin InhibitorsChymotrypsinPlant ProteinsTrypsinTrypsin Inhibitor, Bowman-Birk SoybeanTrypsin Inhibitorsantinutritional factorsBowman–Birk inhibitorCRISPR-Cas9 enabled mutagenesisGlycine max (L. (Merr))soybean

Identifiers

PMID38891766
PMCPMC11171862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.